LAVAL, Quebec, July 12, 2010 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) and Acasti Pharma Inc. ("Acasti") are pleased to announce the outcome of the recent Acasti's Scientific Advisory Board ("SAB") general meeting held on June 15, 2010.
